Spots Global Cancer Trial Database for early stage
Every month we try and update this database with for early stage cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PROgastrine COlon DEpistage | NCT03775473 | Colon Cancer Sc... Healthy Person | progastrin | 50 Years - 80 Years | ECS-Progastrin SA | |
| Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma | NCT00282087 | Leiomyosarcoma Uterine Neoplas... | gemcitabine, do... | 18 Years - | Sarcoma Alliance for Research through Collaboration | |
| Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK | NCT06358573 | Triple-negative... TNBC - Triple-N... | INT230-6 neoadjuvant imm... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | NCT01243190 | Chronic Lymphoc... | Ofatumumab | 18 Years - | M.D. Anderson Cancer Center | |
| Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer | NCT02278965 | Stage 0 Breast ... Breast Neoplasm... Stage I Breast ... Stage II Breast... Stage III Breas... | Metformin Omega-3 fatty a... | 21 Years - 75 Years | Columbia University | |
| Study of Stereotactic Radiotherapy for Breast Cancer | NCT03043794 | Breast Cancer | Stereotactic Bo... | 50 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients | NCT05277688 | Cervical Cancer | adjuvant concur... radiotherapy | 18 Years - 80 Years | Ruijin Hospital | |
| CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC | NCT04452058 | Predictive Canc... Lung Cancer Preinvasive Ade... | Radiomic Algori... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics | NCT05269056 | Early Gastric C... | 18 Years - 75 Years | Zhejiang Cancer Hospital | ||
| Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer | NCT00582842 | Prostate Cancer | Interview survey instrume... | - | Memorial Sloan Kettering Cancer Center | |
| Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions | NCT01399931 | Hodgkin's Lymph... | 18 Years - 60 Years | Ospedale Santa Croce-Carle Cuneo | ||
| Pre-therapeutic MRI Assessment of Early Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery: A New Approach to the Management of Early Stage Rectal Cancer. | NCT04103372 | Rectal Cancer | Surveillance 6 ... Radiotherapy an... surveillance 3 ... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) | NCT01843998 | Cutaneous T-cel... | Sirolimus 0.1% ... | 18 Years - | Medical College of Wisconsin | |
| Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. | NCT02470065 | Non Small Cell ... | Afatinib Immediate surge... | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer | NCT02750358 | Breast Cancer Early Stage Triple Negative... | Enzalutamide assessment | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling | NCT03412643 | HER2-negative B... | Doxorubicin Cyclophosphamid... Weekly Paclitax... Trastuzumab Pertuzumab Celcuity CELx H... | 18 Years - | NSABP Foundation Inc | |
| Pioneering Advances in Care and Education (PACE) | NCT03397160 | Decision Suppor... Prostate Cancer | Decision Suppor... | 18 Years - | University of California, San Francisco | |
| Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma | NCT02301494 | Mycosis Fungoid... | 3.75% Imiquimod... 0.1% Fluocinoni... | 18 Years - | Rochester General Hospital | |
| Impact of Robotic Approach Compared to VATS and Open Approach on Quality of Life in Patients With Lung Cancer | NCT04353349 | Lung Cancer Robotic Thoraci... Video-assisted ... Open Thoracotom... | - | Istituto Clinico Humanitas | ||
| Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma | NCT00282087 | Leiomyosarcoma Uterine Neoplas... | gemcitabine, do... | 18 Years - | Sarcoma Alliance for Research through Collaboration | |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| Impact of Robotic Approach Compared to VATS and Open Approach on Quality of Life in Patients With Lung Cancer | NCT04353349 | Lung Cancer Robotic Thoraci... Video-assisted ... Open Thoracotom... | - | Istituto Clinico Humanitas | ||
| Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma | NCT04373083 | Hodgkin Lymphom... | Cemiplimab Involved-site r... | 18 Years - 75 Years | Regeneron Pharmaceuticals | |
| Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer | NCT05150652 | Breast Cancer HER2-negative B... Node-negative B... Breast Carcinom... | Anastrozole 1mg Letrozole 2.5mg Exemestane 25 m... Tamoxifen | 18 Years - 99 Years | University of Kentucky | |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| Sentinel Lymph Node Mapping in Rectal Cancer | NCT02869152 | Rectal Neoplasm... | Endoscopic inje... Endoscopic inje... Endoscopic inje... Flexible sigmoi... Endoscopic NIR ... Dissection of s... | 18 Years - | University of Virginia | |
| Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | NCT01243190 | Chronic Lymphoc... | Ofatumumab | 18 Years - | M.D. Anderson Cancer Center | |
| CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC | NCT04452058 | Predictive Canc... Lung Cancer Preinvasive Ade... | Radiomic Algori... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| HD16 for Early Stage Hodgkin Lymphoma | NCT00736320 | Hodgkin Lymphom... | ABVD (Adriamyci... 20 Gy IFRT (Inv... | 18 Years - 75 Years | University of Cologne | |
| Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer | NCT00544167 | Breast Cancer | Doxorubicin Cyclophosphamid... Paclitaxel Sorafenib | 18 Years - | SCRI Development Innovations, LLC | |
| CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung Cancer | NCT03916367 | Early Stage Non... | CT-guided Radio... | 18 Years - 85 Years | Peking University Third Hospital | |
| Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model | NCT02451345 | Prostate Cancer | Personalized ri... | 18 Years - | University of California, San Francisco | |
| CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung Cancer | NCT03916367 | Early Stage Non... | CT-guided Radio... | 18 Years - 85 Years | Peking University Third Hospital | |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer | NCT02750358 | Breast Cancer Early Stage Triple Negative... | Enzalutamide assessment | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer | NCT02750358 | Breast Cancer Early Stage Triple Negative... | Enzalutamide assessment | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Stereotactic Radiotherapy for Breast Cancer | NCT03043794 | Breast Cancer | Stereotactic Bo... | 50 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling | NCT03412643 | HER2-negative B... | Doxorubicin Cyclophosphamid... Weekly Paclitax... Trastuzumab Pertuzumab Celcuity CELx H... | 18 Years - | NSABP Foundation Inc | |
| Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. | NCT01045109 | Prostate Cancer | cholecalciferol cholecalciferol | 18 Years - 90 Years | Medical University of South Carolina | |
| Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer | NCT00544167 | Breast Cancer | Doxorubicin Cyclophosphamid... Paclitaxel Sorafenib | 18 Years - | SCRI Development Innovations, LLC | |
| RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) | NCT03643861 | Breast Cancer | 5 Fraction Ster... | 18 Years - 99 Years | University of Alabama at Birmingham | |
| Pre-therapeutic MRI Assessment of Early Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery: A New Approach to the Management of Early Stage Rectal Cancer. | NCT04103372 | Rectal Cancer | Surveillance 6 ... Radiotherapy an... surveillance 3 ... | 18 Years - | Royal Marsden NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
